PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. - Wikidata - wikimedia - TriplyDB

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

http://www.wikidata.org/entity/Q33603896

about

Therapy of hypoparathyroidism by replacement with parathyroid hormone Management of Hypoparathyroidism: Present and Future.Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism Parathyroid hormone 1-84 alters circulating vascular endothelial growth factor levels in hypoparathyroidism.PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy Parathyroid hormone therapy for hypoparathyroidism Use of parathyroid hormone in hypoparathyroidism.PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.Noninvasive Assessment of Skeletal Microstructure and Estimated Bone Strength in Hypoparathyroidism.The effect of PTH(1-84) on quality of life in hypoparathyroidism.Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.Mini-review: new therapeutic options in hypoparathyroidism.Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.Recovery of parathyroid hormone secretion and function in postoperative hypoparathyroidism: a case series.Review of Hypoparathyroidism.PTH replacement therapy of hypoparathyroidism.Recombinant hormones in osteoporosis.Bone disease in hypoparathyroidism.Impact of recombinant PTH on management of hypoparathyroidism: a systematic review.The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study.Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.Natpara for the treatment of hypoparathyroidism.Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.Bone imaging in hypoparathyroidism.The Epidemiology of Hypoparathyroidism in Italy: An 8-Year Register-Based Study.A Pediatric Patient with a CYP24A1 Mutation: Four Years of Clinical, Biochemical, and Imaging Follow-Up.Effects of Daily or Cyclic Teriparatide on Bone Formation in the Iliac Crest in Women on No Prior Therapy and in Women on Alendronate.Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys.Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study.Continuous Subcutaneous Recombinant Parathyroid Hormone (1-34) Infusion in the Management of Childhood Hypoparathyroidism Associated with Malabsorption.Hypoparathyroidism.

P2860

Q26828582-6657C729-C963-4DF0-8D85-8A35456EA29E Q33570607-4E2E0836-DFAE-4FDD-BFFF-D0AA5B2153CA Q33609120-CE6AC57A-B9DB-4DBF-87DC-862A244C7A26 Q34284726-A9F61397-3236-4FEA-AC77-24988516F6A6 Q34284783-CA038843-BD29-429B-8B0E-319195C9D658 Q35014795-30955C18-3B07-4DC1-BCF7-8452536C3046 Q35043115-BDF4C865-BEC8-4A2C-9ECD-2502E10E46B6 Q35100381-69D991AB-6E1A-48D1-9DA1-EE50B576A350 Q36103534-C8B0689B-4F43-41EA-AA1C-884478F2B3BA Q36508951-44E2F859-8DA7-4A22-8D6C-875612DE7465 Q36795949-B6C1AB60-1780-4BAB-8146-6713E95C4054 Q36800736-2F298816-E6A0-4E96-9182-AC32F755B834 Q36885818-C9635E8C-09C7-42CE-86F9-C6C39F3126C0 Q36889099-4276048D-D925-4FE8-8EA3-FF7755EC48D0 Q36935525-F55E144A-913A-4659-B796-6577F996406B Q36949203-A851CF27-F5ED-46AE-90EE-65BCF0C66890 Q37057936-080F4FAD-D8FB-45F3-B450-5871697A0C9C Q37275957-E5F27446-294A-4013-A85B-721CE53EEF2F Q37587224-80565EA1-FEC1-4B6F-97BD-13C7F35EA40E Q38062849-7F9A2C6C-70B4-4F2E-A6F0-01203B303E55 Q38104374-F369C750-C349-4334-A3BB-ED33EBE3EE78 Q38244174-D85DFBC3-3F3B-4D3B-AB9D-557832D66C25 Q38310672-C5344D01-38C7-48DD-9009-6C6C86594182 Q38370979-51F7DC08-A120-4B30-B151-FC1D072946A7 Q38547732-F1521F23-C1A8-4011-A456-DF67BE58AD95 Q38816021-81BE277C-EEAB-45A2-A57D-5A4F0BE5CE54 Q38884368-280D57DB-4FA6-4644-9245-47A7B8F7CFE5 Q38941679-62C2ACDF-795D-43B7-A1C0-4751FCFBB2C6 Q39067240-9EFD0362-A236-4EF1-8DCF-93F7170BEE1F Q39230407-06344B4E-9B5E-40D9-94F1-8B09E00D519C Q39967346-4D114BEF-992D-4738-9DF1-1AC6FE3F9D60 Q40946883-DBB43BEA-B81C-4776-B809-C45DEA2F01B4 Q42014841-CBA0F59A-8553-4E7C-9120-883796E0091C Q47683848-8F646DF4-6DB9-4364-BEED-0F5415E28D1E Q50018918-21B42D22-F74B-43F3-9EDC-C00538643088 Q51799713-40614D97-4E67-449F-A8C4-1ECAF52275E6

P2860

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

http://www.wikidata.org/entity/Q33603896

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

PTH(1-84) administration rever ...... ructure in hypoparathyroidism.

@ast

PTH(1-84) administration rever ...... ructure in hypoparathyroidism.

@en

type

label

PTH(1-84) administration rever ...... ructure in hypoparathyroidism.

@ast

PTH(1-84) administration rever ...... ructure in hypoparathyroidism.

@en

prefLabel

PTH(1-84) administration rever ...... ructure in hypoparathyroidism.

@ast

PTH(1-84) administration rever ...... ructure in hypoparathyroidism.

@en

P1433

Q33603896-AB818E01-8E6D-4D8D-BF5D-699D01D72126

P1476

Q33603896-F2EE6408-5653-405F-9920-7576C8980524

P2093

Q33603896-153AD156-6A13-4198-9E83-C79AA15830EC

Q33603896-3FAB3CDF-D172-4CAE-84D8-6443528B7152

Q33603896-4AC4B3A1-C288-44F9-859D-5A238E56AB4B

Q33603896-5854FFE8-6F74-4376-9D9A-A5E1FA6F32A0

Q33603896-73D28CFB-8A12-426A-B64B-86BAE7DBAB3E

Q33603896-831D23D3-9634-42EE-8A50-99977C845894

Q33603896-91C43FB4-5710-4293-86F3-30396071955F

Q33603896-96B8AC20-A55D-47AA-B4C5-904575B460C2

Q33603896-B233D846-D914-4400-9290-BC488452C2AB

Q33603896-B79C9E84-2C72-4A37-9D90-07FD817BF68F

P2860

Q33603896-14D38ED2-4C23-458C-B9D7-1945D22BB6D5

Q33603896-1F1DEB86-8460-40FF-A958-C8DBCA2AADC5

Q33603896-2684C298-DECF-43B4-9E7F-504487E5ED74

Q33603896-298EDFDF-609E-4851-8986-A17C138F0253

Q33603896-2C605E6B-DF01-4624-81D0-E6FA8B298927

Q33603896-2E39322C-04B0-45FD-8E66-47ACBDA4E3D8

Q33603896-326C6461-AEE3-4235-A99F-9B71D579432C

Q33603896-33FD4787-48A2-4478-B014-553E3A125BB9

Q33603896-6411A7A1-28F7-4B92-B8A9-22826CC73052

Q33603896-7555D813-6807-4A0B-A469-88594073AEAD

P304

Q33603896-1447F887-DA1D-4742-817C-CC430A0057C8

P31

Q33603896-BDF1CCB6-A781-4B21-9185-0FFAAEEF7FB4

P356

Q33603896-C37DA348-CDBF-407D-8632-818B54908D10

P433

Q33603896-B56D176E-B045-41A2-BB8A-8D3EF777AF89

P478

Q33603896-F15F8CEF-E530-4365-B877-7FCA5B993D42

P50

Q33603896-2BE00BF1-4224-46ED-8273-D70F3E75C92F

P577

Q33603896-FB420E79-38E2-4D4B-8DDF-F8B9FD45F329

P5875

Q33603896-9DF6ABDD-183E-45ED-9D03-23B9268DD4AD

P698

Q33603896-AF3D74EB-BCE8-4B2D-AB70-A09A4C41636C

P932

Q33603896-88EF30A5-511B-4592-B57A-EEBB50AA9C81

P356

P1433

Journal of Bone and Mineral Research

P1476

PTH(1-84) administration rever ...... ructure in hypoparathyroidism.

@en

P2093

Chiyuan Zhang

http://www.w3.org/2001/XMLSchema#string

David W Dempster

http://www.w3.org/2001/XMLSchema#string

Donald J McMahon

http://www.w3.org/2001/XMLSchema#string

Elizabeth Shane

http://www.w3.org/2001/XMLSchema#string

Elzbieta Dworakowski

http://www.w3.org/2001/XMLSchema#string

Emily M Stein

http://www.w3.org/2001/XMLSchema#string

Hua Zhou

http://www.w3.org/2001/XMLSchema#string

James Sliney

http://www.w3.org/2001/XMLSchema#string

Maryann Dellabadia

http://www.w3.org/2001/XMLSchema#string

Mishaela R Rubin

http://www.w3.org/2001/XMLSchema#string

P2860

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Three dimensional cancellous bone structure in hypoparathyroidism

Therapy of hypoparathyroidism with intact parathyroid hormone.

Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females.

Changes in quantitative bone histomorphometry in aging healthy men.

Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.

Parathyroid function and the renal excretion of 3'5'-adenylic acid.

Differential effects of endocrine dysfunction on the axial and the appendicular skeleton

Dynamic and structural properties of the skeleton in hypoparathyroidism.

P304

2727-2736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.452

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

John P. Bilezikian

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230009584

http://www.w3.org/2001/XMLSchema#string

P698

21735476

http://www.w3.org/2001/XMLSchema#string

P932

4019384

http://www.w3.org/2001/XMLSchema#string